Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

Indian benchmark indices ended in the red on Friday, extending their losing streak to a third consecutive week. The decline was driven by losses in heavyweight financial and automobile stocks, while ...

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs ...

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, ...

IST, the barometer index, the S&P BSE Sensex, declined 461.33 points or 0.61% to 75,274.63. The Nifty 50 index slipped 139.85 points or 0.63% to 22,768.05.

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

Zee Business Managing Editor Anil Singhvi shares his strategy for today's session on Dalal Street. Learn more about his views ...

Stocks including Quality Power, M&M, NTPC Green, Tata Steel, Cipla, RVNL, Delta Corp, HG Infra and Berger Paints will be in the spotlight on Friday, February 21.

Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...

The NSE Nifty 50 closed 19.75 points or 0.09% lower at 22,913.15, while the BSE Sensex ended 203.22 points or 0.27% down at ...

Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...